ArticleJournal of experimental & clinical cancer research : CR2026
Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.
Kathryn A F Pennel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.